当前位置: 首页 SCI 期刊 医学 Korean Journal Of Physiology & Pharmacology(非官网)
Korean Journal Of Physiology & Pharmacology

Korean Journal Of Physiology & PharmacologySCIE

国际简称:KOREAN J PHYSIOL PHA  参考译名:韩国生理学与药理学杂志

  • 中科院分区

    4区

  • CiteScore分区

    Q3

  • JCR分区

    Q3

基本信息:
ISSN:1226-4512
E-ISSN:2093-3827
是否OA:开放
是否预警:否
TOP期刊:否
出版信息:
出版地区:Korea
出版商:Korean Physiological Soc. and Korean Soc. of Pharmacology
出版语言:English
出版周期:Bimonthly
出版年份:1997
研究方向:PHARMACOLOGY & PHARMACY-PHYSIOLOGY
评价信息:
影响因子:1.6
H-index:23
CiteScore指数:3.2
SJR指数:0.405
SNIP指数:0.447
发文数据:
Gold OA文章占比:100.00%
研究类文章占比:94.12%
年发文量:51
自引率:0.05
开源占比:1
出版撤稿占比:0
出版国人文章占比:0.2
OA被引用占比:0.3623...
英文简介 期刊介绍 CiteScore数据 中科院SCI分区 JCR分区 发文数据 常见问题

英文简介Korean Journal Of Physiology & Pharmacology期刊介绍

The Korean Journal of Physiology & Pharmacology (Korean J. Physiol. Pharmacol., KJPP) is the official journal of both the Korean Physiological Society (KPS) and the Korean Society of Pharmacology (KSP). The journal launched in 1997 and is published bi-monthly in English. KJPP publishes original, peer-reviewed, scientific research-based articles that report successful advances in physiology and pharmacology. KJPP welcomes the submission of all original research articles in the field of physiology and pharmacology, especially the new and innovative findings. The scope of researches includes the action mechanism, pharmacological effect, utilization, and interaction of chemicals with biological system as well as the development of new drug targets. Theoretical articles that use computational models for further understanding of the physiological or pharmacological processes are also welcomed. Investigative translational research articles on human disease with an emphasis on physiology or pharmacology are also invited. KJPP does not publish work on the actions of crude biological extracts of either unknown chemical composition (e.g. unpurified and unvalidated) or unknown concentration. Reviews are normally commissioned, but consideration will be given to unsolicited contributions. All papers accepted for publication in KJPP will appear simultaneously in the printed Journal and online.

期刊简介Korean Journal Of Physiology & Pharmacology期刊介绍

《Korean Journal Of Physiology & Pharmacology》自1997出版以来,是一本医学优秀杂志。致力于发表原创科学研究结果,并为医学各个领域的原创研究提供一个展示平台,以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述,从广泛的视角提供当前感兴趣的研究主题的新见解,或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单,目前已被权威数据库SCIE收录,得到了广泛的认可。

该期刊投稿重要关注点:

Cite Score数据(2024年最新版)Korean Journal Of Physiology & Pharmacology Cite Score数据

  • CiteScore:3.2
  • SJR:0.405
  • SNIP:0.447
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q3 202 / 313

35%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Physiology Q3 138 / 193

28%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础,针对的是前四年发表的论文的引文。CiteScore的意义在于,它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法,而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Korean Journal Of Physiology & Pharmacology 中科院分区

中科院 2023年12月升级版 综述期刊:否 Top期刊:否
大类学科 分区 小类学科 分区
医学 4区 PHARMACOLOGY & PHARMACY 药学 PHYSIOLOGY 生理学 4区 4区

中科院分区表 是以客观数据为基础,运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据,得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次,类似于“优、良、及格”等。最开始,这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Korean Journal Of Physiology & Pharmacology JCR分区

2023-2024 年最新版
按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 259 / 354

27%

学科:PHYSIOLOGY SCIE Q4 68 / 85

20.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 218 / 354

38.56%

学科:PHYSIOLOGY SCIE Q4 66 / 85

22.94%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异,此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此,JCR将期刊按照学科门类和影响因子分为不同的分区,这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计
  • 国家/地区数量
  • South Korea135
  • CHINA MAINLAND42
  • USA13
  • India3
  • Japan3
  • Egypt2
  • Mexico2
  • Saudi Arabia2
  • Taiwan2
  • Vietnam2

本刊中国学者近年发表论文

  • 1、SKF96365 impedes spinal glutamatergic transmission-mediated neuropathic allodynia

    Author: Wang, Qiru; Zhang, Yang; Du, Qiong; Zhao, Xinjie; Wang, Wei; Zhai, Qing; Xiang, Ming

    Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 39-48. DOI: 10.4196/kjpp.2023.27.1.39

  • 2、GBA inhibition suppresses ovarian cancer growth, survival and receptor tyrosine kinase AXL-mediated signaling pathways

    Author: Wang, Gang; Ouyang, Baisha; Jing, Fang; Dai, Xiaoyan

    Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 21-29. DOI: 10.4196/kjpp.2023.27.1.21

  • 3、Hydrogen sulfide alleviates hypothyroidism-induced myocardial fibrosis in rats through stimulating autophagy and inhibiting TGF-(31/Smad2 pathway

    Author: Song, Xiong; Nie, Liangui; Long, Junrong; Zhao, Junxiong; Liu, Xing; Wang, Liuyang; Liu, Da; Wang, Sen; Liu, Shengquan; Yang, Jun

    Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 1-8. DOI: 10.4196/kjpp.2023.27.1.1

  • 4、Exosome-mediated lnc-ABCA12-3 promotes proliferation and glycolysis but inhibits apoptosis by regulating the tolllike receptor 4/nuclear factor kappa-B signaling pathway in esophageal squamous cell carcinoma

    Author: Ma, Junliang; Luo, Yijun; Liu, Yingjie; Chen, Cheng; Chen, Anping; Liang, Lubiao; Wang, Wenxiang; Song, Yongxiang

    Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 61-73. DOI: 10.4196/kjpp.2023.27.1.61

  • 5、Momordicine I alleviates isoproterenol-induced cardiomyocyte hypertrophy through suppression of PLA2G6 and DGK-?

    Author: Li, Hongming; Qiu, Yumei; Xie, Mengdie; Ouyang, Changsheng; Ding, Xiaoyun; Zhang, Hao; Dong, Wei; Xiong, Yinhua; Tang, Xilan

    Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 1, pp. 75-84. DOI: 10.4196/kjpp.2023.27.1.75

  • 6、Combination of canagliflozin and puerarin alleviates the lipotoxicity to diabetic kidney in mice

    Author: Zhu, Qian; Zhou, Qu; Luo, Xiao-li; Zhang, Xu-jie; Li, San-yu

    Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 3, pp. 221-230. DOI: 10.4196/kjpp.2023.27.3.221

  • 7、Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression

    Author: Zheng, Wan; Li, Tianfa; Wei, Junping; Yan, Yani; Yang, Shanshan

    Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 3, pp. 209-220. DOI: 10.4196/kjpp.2023.27.3.209

  • 8、LINC00562 drives gastric cancer development by regulating miR-4636-AP1S3 axis

    Author: Xu, Lin; Liu, Daiting; Wang, Xun

    Journal: KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY. 2023; Vol. 27, Issue 3, pp. 197-208. DOI: 10.4196/kjpp.2023.27.3.197

投稿常见问题

通讯方式:KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, C/O EDITORIAL OFFICE, 448-13 SEOKYO-DONG, SEOUL, SOUTH KOREA。